EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Continuous Glucose Monitoring Metrics as a Predictor of Acute Complications in Youth with Type 1 Diabetes

Julie K Sklar, Lisa K Volkening, Liane J Tinsley, Lori M Laffel iD

Diabetes Technology & Therapeutics · 2025

DOI: 10.1089/dia.2025.0233 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Julie K Sklar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Blood Glucose, Hypoglycemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous glucose monitors (CGMs) offer insight into glycemic control but have not been established as predictors of acute diabetes complications. Using data from 120 youth with type 1 diabetes (ages 8–17) enrolled in a 24-month study, we investigated associations of CGM-derived metrics (time-in-range [TIR] 70–180 mg/dL, time 180, time >250, mean glucose, glucose coefficient of variation [CV]) with incidence rates of severe hypoglycemia and diabetic ketoacidosis (DKA)/severe hyperglycemia. Over 285 person-years of follow-up, there were 75 events of severe hypoglycemia and 15 events of DKA/severe hyperglycemia. TIR and CV were significantly associated with severe hypoglycemia. Those with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Continuous Glucose MonitoringBlood GlucoseHypoglycemiaDiabetic KetoacidosisHumansMaleFemaleChildAdolescentPredictive Value of TestsGlycemic ControlIncidence

Stichwörter der Autor:innen

continuous glucose monitoringdiabetic ketoacidosis (DKA)hyperglycemiahypoglycemiatype 1 diabetesyouth

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, Connecticut, USA.
  • Section on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.

ORCID-Profile: Lori M Laffel

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Sklar, J. K., Volkening, L. K., Tinsley, L. J., & Laffel, L. M. (2025). Continuous Glucose Monitoring Metrics as a Predictor of Acute Complications in Youth with Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2025.0233

Vancouver

Sklar JK, Volkening LK, Tinsley LJ, Laffel LM. Continuous Glucose Monitoring Metrics as a Predictor of Acute Complications in Youth with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2025.0233

BibTeX
@article{Sklar2025,
  author = {Sklar, Julie K and Volkening, Lisa K and Tinsley, Liane J and Laffel, Lori M},
  title = {Continuous Glucose Monitoring Metrics as a Predictor of Acute Complications in Youth with Type 1 Diabetes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2025},
  doi = {10.1089/dia.2025.0233}
}
Kostenlos starten →